Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
39 studies found for:    Antiphospholipid Syndrome
Show Display Options
Rank Status Study
21 Recruiting Phase IIa Trial of ALXN1007 for the Treatment of Non-criteria Manifestations of Antiphospholipid Syndrome
Condition: Antiphospholipid (aPL)-Positive
Intervention: Biological: Study Drug- ALXN1007
22 Recruiting The Influence of Antiphospholipid Antibodies on the Relationship Between Hyperurecemia, Gout and Metabolic Syndrome
Conditions: Antiphospholipid Syndrome;   Endothelial Dysfunction;   Hyperuricemia;   Gout;   Metabolic Syndrome
Intervention:
23 Recruiting Effect of HCQ on AnxA5 Resistance Assay in Antiphospholipid (aPL) Positive Patients With and Without Systemic Lupus Erythematosus (SLE)
Conditions: Antiphospholipid Syndrome;   Thrombophilia Due to Antiphospholipid Antibody;   Systemic Lupus Erythematosus
Intervention: Other: Phlebotomy
24 Not yet recruiting Antiphospholipid Antibodies and Early Severe Preeclampsia.
Conditions: Severe Preeclampsia;   Antiphospholipid Syndrome
Intervention:
25 Not yet recruiting Antiphospholipid Antibodies and Fetal Growth Restriction
Conditions: Fetal Growth Restriction;   Antiphospholipid Syndrome
Intervention:
26 Unknown  Safety and Efficacy of Anti-Pandemic H1N1 Vaccination in Rheumatic Diseases
Conditions: Rheumatoid Arthritis;   Spondyloarthritis;   Systemic Lupus Erythematosus (SLE);   Dermatomyositis (DM);   DMixed Connective Tissue Disease;   Systemic Vasculitis;   Systemic Sclerosis (SSc);   Sjögren's Syndrome;   Antiphospholipid Syndrome;   Juvenile Idiopathic Arthritis;   Juvenile SLE;   Juvenile DM
Intervention: Biological: Anti-pandemic H1N1 influenza vaccine
27 Completed CI(R)CA : Coumadin Interaction With Rofecoxib, Celecoxib and Acetaminophen
Condition: Antiphospholipid Antibody Syndrome
Interventions: Drug: Celecoxib;   Drug: Acetaminophen;   Drug: Rofecoxib;   Drug: placebo
28 Unknown  Longitudinal Study of the Clinical and Haematological Cause of Women With Antiphospholipid Antibodies.
Condition: Antiphospholipid Syndrome
Intervention:
29 Recruiting Hydroxychloroquine for the First Thrombosis Prevention in Antiphospholipid Antibody Positive Patients
Condition: Antiphospholipid Syndrome
Intervention: Drug: Hydroxychloroquine
30 Recruiting Pharmacogenetics of Warfarin in Puerto Ricans.
Conditions: Atrial Fibrillation;   Deep Vein Thrombosis;   Cardiac Valvular Insufficiency;   Antiphospholipid Syndrome;   Coagulopathy
Intervention:
31 Completed Drug Interaction Between Paracetamol and Warfarin
Conditions: Deep Venous Thrombosis;   Pulmonary Embolism;   Atrial Fibrillation;   Stroke;   Antiphospholipid Syndrome
Interventions: Drug: paracetamol;   Drug: Placebo
32 Terminated Low Molecular Weight Heparin and Aspirin in the Treatment of Recurrent Pregnancy Loss: A RCT
Conditions: Recurrent Pregnancy Loss;   Antiphospholipid Antibody Syndrome
Interventions: Drug: Low molecular weight heparin and low dose aspirin;   Drug: Low dose aspirin
33 Unknown  Low Molecular Weight Heparin in Recurrent Miscarriage With Negative Antiphospholipid Antibodies
Condition: Recurrent Miscarriage
Interventions: Drug: LMWH+Folic acid;   Drug: Folic Acid
34 Active, not recruiting Pharmacokinetics of Low Molecular Weight and Unfractionated Heparin in Pregnancy
Conditions: Recurrent Pregnancy Loss,;   Fetal Demise;   Abortion, Habitual;   Antiphospholipid Antibodies;   Inherited Thrombophilia
Intervention:
35 Recruiting Beneficial Effects of Coenzyme Q10 Treatment on the Mitochondrial Dysfunction and Oxidative Stress Associated to Atherothrombosis Developement in Antiphospholipidid Syndrome Patients
Condition: Coenzyme Q10 on Athero-thrombosis in APS Patients
Interventions: Drug: CoQ10;   Drug: Placebo
36 Unknown  Infections and Autoimmunity: Autobodies Screening in Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Procedure: Serum antibodies to infectious agents using the BioPlex 2200 and complementary EIA kits
37 Recruiting Nonmyeloablative Allo Stem Cell Transplant for Severe Autoimmune Diseases
Conditions: Systemic Lupus Erythematosus;   Systemic Sclerosis
Intervention: Procedure: Nonmyeloablative allogeneic stem cell transplant
38 Recruiting Evaluation of the Duration of Therapy for Thrombosis in Children
Condition: Venous Thrombosis
Interventions: Other: Shortened duration (6 weeks) of anticoagulant therapy;   Other: Conventional duration (3 months) of anticoagulant therapy;   Other: No Intervention
39 Completed Observational Study in UTERO - Placental 3D Doppler Examination: Interest for Pre-eclampsia Screening During Pregnancy
Conditions: Pre-eclampsia;   Intra-uterine Growth Restriction;   Placental Insufficiency;   3D Doppler Ultrasound.
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-39) Next Page   
Indicates status has not been verified in more than two years